Lv1
30 积分 2024-08-25 加入
Clinical outcomes and microenvironment profiling in relapsed/ refractory multiple myeloma patients with extramedullary disease receiving anti-BCMA CAR T-cell-based therapy
2小时前
已完结
A CAR enhancer increases the activity and persistence of CAR T cells
1个月前
已完结
Anti-BCMA/GPRC5D bispecific CAR T cells in patients with relapsed or refractory multiple myeloma: a single-arm, single-centre, phase 1 trial
3个月前
已完结
皖公网安备34019202002308
